Agape ATP Corp. (ATPC): Price to Sales

Corporate company logo of Agape ATP Corporation (ATPC)

Agape ATP Corporation (ATPC) is actively expanding its digital wellness services in Asia to capture the metabolic medicine niche. The current price-to-sales ratio displayed on GURU.Markets reflects valuation dynamics, where the value 1.20 captures the metric level. The business is currently transitioning toward moderate profit growth amid stabilizing demand, despite pressure from new entrants and the trend toward natural ingredients.

Agape ATP Corp. - ATPC P/S Multiple (period 02/21/2024 - 11/14/2026)

Metric breakdowns and analytics for Agape ATP Corp (ATPC)

- current price and projected stock value:
Price Chart Agape ATP Corp|ATPC - Price Target Chart
- stock exchange capitalization data:
Market Value Agape ATP|ATPC - Total Company Value
- shareholders' equity book value data:
Net Assets per Single Share Agape ATP|ATPC - Book Capitalization|Market Capitalization to Book Value agapeatpgroup.com|ATPC - Aggregate Company Assets
- issuer credit burden and liquidity indicators:
Total Debt to Capital Coefficient Agape ATP Corporation|ATPC - Long-Term Debt to Equity|Short-Term Debt to Equity Ratio Agape ATP|ATPC - Company Aggregate Debts|Debts to Book Capitalization Agape ATP Corporation|ATPC - Company Long-Term Debts|Short-Term Indebtedness Agape ATP|Quick Ratio agapeatpgroup.com
- financial results and valuation multiples details:
ATPC - Company Net Income|Forward Earnings Agape ATP Corporation|ATPC - P/E Multiple|Projected Price to Earnings Ratio Agape ATP Corp.|ATPC - Price/Earnings to Growth Multiple|Business Value to Operating Income Before Depreciation Agape ATP Corporation|ATPC - Operating profit EBITDA|Net earnings per share (EPS TTM) Agape ATP|ATPC - Net earnings per share for the last 12 months|Year-over-year earnings per share growth rate for the last twelve months agapeatpgroup.com|ATPC - Earnings per share growth in current year|Net earnings per share change forecast for next year Agape ATP Corporation
- issuer revenue and sales details:
ATPC - Company Sales|Company Future Revenue Agape ATP|ATPC - P/S Multiple|Forward Price-to-Revenue Multiple Agape ATP
General company analysis:ATPC Agape ATP Corp.
Core merchandise of Agape ATP

The fundamental risk of undervaluation or overpayment is determined by comparing market capitalization with actual cash flow. For Agape ATP Corporation (ATPC), high margins driven by a loyal community in Southeast Asia should support multiplier stability. The calculated price-to-sales ratio reflects how much investors are willing to pay per unit of sales, filtering out market noise. An increase in this indicator signals inflated expectations, while a decrease suggests an undervaluation of the business model.

Competing companies

Price-to-Revenue Ratio ASND (Ascendis Pharma AS)|Price-to-Revenue Ratio madrigalpharma.com MDGL|Corcept Therapeutics Corp (CORT) - Price to Sales|RYTM - Price-to-Revenue Ratio|AKRO: Price-to-Revenue Ratio|MTSR: P/S Multiple|MLTX - Price-to-Revenue Coefficient|Price-to-Revenue Ratio Crinetics Corp|NewAmsterdam Pharma Corp (NAMS) - Price-to-Revenue Coefficient|Price-to-Revenue Ratio soleno.life (SLNO)|Market Cap to Revenue Amicus Therapeutics FOLD|Market Capitalization-to-Revenue Ratio 89bio Inc|P/S Multiple Agios Pharmaceuticals, Inc. AGIO|GPCR: Market Cap to Revenue|Price-to-Revenue Coefficient MiMedx Corp MDXG|RZLT (Rezolute Corp) - Market Cap to Revenue|Market Cap to Revenue Ratio LXRX|MBX (MBX Biosciences) - P/S Multiple|Market Cap to Revenue Altimmune Inc (ALT)|Market Cap to Revenue AARD (Aardvark Therapeutics Corp)|Market Cap to Revenue Sagimet SGMT|P/S Multiple BIOA (BioAge Labs)|P/S Multiple Biomea Fusion BMEA|QNCX: Market Cap to Revenue|GUTS: Price-to-Revenue Ratio|vTv Therapeutics Inc (VTVT) - Price-to-Revenue Ratio|Market Cap to Revenue Ratio PLUR|Market Cap to Revenue SYBX|LPCN: Market Capitalization-to-Revenue Ratio|P/S Multiple MTNB|SPRB - Price to Sales|P/S Multiple GLTO (Galecto Corporation)|Market Capitalization-to-Revenue Ratio CTCX|Lumos Therapeutics - P/S Multiple|ONVO: Price-to-Revenue Ratio|Radius Recycling (RDUS) - Price-to-Revenue Ratio